Utopia SIS has invested in PerFormS Srl, a healthcare spin-off from the University of Modena and Reggio Emilia, with an 80% investment guarantee from Medio Credito Centrale, to support its research in treating chronic psoriasis.
Target Information
PerFormS Srl is a spin-off from the University of Modena and Reggio Emilia, supported in its development over the past few years by the G-Factor incubator of the Golinelli Foundation in Bologna. The company focuses on research for treating chronic psoriasis and has developed an innovative approach to medicine.
Recently, Utopia SIS, an investment company specializing in healthcare and biomedical sectors, funded PerFormS Srl. The investment is backed by an 80% guarantee from the Medio Credito Centrale, helping the startup continue its promising research.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Italy
The healthcare and biomedical industry in Italy is notable for its significant investments in research and development, particularly in therapeutic innovations. With a strong emphasis
Similar Deals
CDP Venture Capital → Arsenale Bioyards
2025
Utopia SIS and Pariter Partners → LighthouseBiotech
2023
Italian Angels for Growth, Club degli Investitori, Doorway → AorticLab
2023
Utopia SIS
invested in
PerFormS Srl
in 2023
in a Seed Stage deal